Corrigendum to: Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials
- PMID: 31898727
- DOI: 10.1093/europace/euz363
Corrigendum to: Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials
Erratum for
-
Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials.Europace. 2020 Jan 1;22(1):33-46. doi: 10.1093/europace/euz259. Europace. 2020. PMID: 31603196
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous